Osmotica Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OSMOTICA PHARM, and what generic and branded alternatives to OSMOTICA PHARM drugs are available?
OSMOTICA PHARM has nine approved drugs.
Drugs and US Patents for Osmotica Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Osmotica Pharm Us | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205327-004 | Jul 28, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Osmotica Pharm Us | DONEPEZIL HYDROCHLORIDE | donepezil hydrochloride | TABLET;ORAL | 203114-001 | Jan 26, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Osmotica Pharm Us | RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 216117-005 | Jun 23, 2022 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Osmotica Pharm Us | RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 216117-004 | Jun 23, 2022 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Osmotica Pharm Us | RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 216117-006 | Jun 23, 2022 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Osmotica Pharm Us | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022104-001 | May 20, 2008 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Osmotica Pharm
Similar Applicant Names
Here is a list of applicants with similar names.